ERBB2 and triple-negative breast carcinoma: Although not perfectly aligned, the luminal-like, Her2-enriched, and basal-like subtypes correlate with ERα +ve, HER2 +ve, and triple negative breast cancer subtypes identified by immunohistochemistry.